1. Home
  2. BHVN vs SHOO Comparison

BHVN vs SHOO Comparison

Compare BHVN & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • SHOO
  • Stock Information
  • Founded
  • BHVN 2013
  • SHOO 1990
  • Country
  • BHVN United States
  • SHOO United States
  • Employees
  • BHVN N/A
  • SHOO N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • SHOO Shoe Manufacturing
  • Sector
  • BHVN Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • BHVN 2.9B
  • SHOO 2.8B
  • IPO Year
  • BHVN 2017
  • SHOO 1993
  • Fundamental
  • Price
  • BHVN $27.65
  • SHOO $26.65
  • Analyst Decision
  • BHVN Strong Buy
  • SHOO Hold
  • Analyst Count
  • BHVN 14
  • SHOO 6
  • Target Price
  • BHVN $63.15
  • SHOO $40.20
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • SHOO 1.9M
  • Earning Date
  • BHVN 03-03-2025
  • SHOO 04-30-2025
  • Dividend Yield
  • BHVN N/A
  • SHOO 3.15%
  • EPS Growth
  • BHVN N/A
  • SHOO 2.17
  • EPS
  • BHVN N/A
  • SHOO 2.35
  • Revenue
  • BHVN N/A
  • SHOO $2,282,927,000.00
  • Revenue This Year
  • BHVN N/A
  • SHOO $15.42
  • Revenue Next Year
  • BHVN $65.26
  • SHOO $7.97
  • P/E Ratio
  • BHVN N/A
  • SHOO $11.34
  • Revenue Growth
  • BHVN N/A
  • SHOO 15.21
  • 52 Week Low
  • BHVN $26.57
  • SHOO $24.56
  • 52 Week High
  • BHVN $55.72
  • SHOO $50.01
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 35.77
  • SHOO 34.15
  • Support Level
  • BHVN $28.22
  • SHOO $26.75
  • Resistance Level
  • BHVN $31.18
  • SHOO $27.51
  • Average True Range (ATR)
  • BHVN 1.56
  • SHOO 0.99
  • MACD
  • BHVN 0.20
  • SHOO 0.53
  • Stochastic Oscillator
  • BHVN 23.43
  • SHOO 61.29

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: